DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ advanced 1.06% to $453.06 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.58% to 7,444.25 and the Dow Jones Industrial Average falling 0.14% to 49,693.20.
This was the stock's fourth consecutive day of gains.
Vertex Pharmaceuticals Inc. closed 10.80% short of its 52-week high of $507.92, which the company achieved on March 10th.
The stock outperformed some of its competitors Wednesday, as AbbVie Inc. $(ABBV)$ rose 0.31% to $208.50, Krystal Biotech Inc. (KRYS) rose 0.73% to $312.58, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 0.12% to $8.26.
Trading volume (1.2 M) remained 104,045 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 13, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 13, 2026 16:38 ET (20:38 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments